Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

Zhao C, Xiang Z, Li M, Wang H, Liu H, Yan H, Huang M

Journal of Hepatocellular Carcinoma 2023, 10:1195-1206

Published Date: 25 July 2023